Duda, Dan, DMD, PhD
Dan G. Duda obtained his DMD from the University of Medicine Iasi, Romania in 1993, and earned his PhD in Medical Sciences (GI Surgery) from Tohoku University Graduate School of Medicine, Sendai, Japan in 2001. After graduation, he joined as a Postdoctoral Fellow the Steele Laboratories for Tumor Biology in the Department of Radiation Oncology at Massachusetts General Hospital and Harvard Medical School in Boston. After becoming junior Faculty member (Instructor) in 2004, he rose through the ranks to Associate Professor of Tumor Biology in 2012.
His current research efforts focus on the role of the interactions between locally derived stroma (tumor-associated vessels, fibroblasts) and distant stroma (inflammatory cells) with cancer cells in tumor progression and resistance to treatment. The goal is to identify new targets for therapy and biomarkers of response in translational studies, particularly in intractable cancers. He has authored over 160 publications so far, of which 92 are original reports, including articles in Nature, Nature Genetics, Nature Medicine, Cell, Cancer Cell, PNAS and Journal of Clinical Oncology. He has been invited to present these studies at over 120 local, national and international meetings, including as plenary speaker and keynote speaker.
For his work, Dr. Duda received several awards from the AACR, CRI, IASGO and MGH. He is an Honorary Member of the Academy of Medical Sciences of Romania since 2012. He has served as a panel member for multiple scientific expert meetings worldwide. His research is currently supported by grants from the US National Cancer Institute, Massachusetts General Hospital ECOR, Andrew L. Warshaw, MD, Institute for Pancreatic Cancer and The Samuel Singer Brown Fund for Pancreatic Ductal Adenocarcinoma Research, as well as by partnerships with Industry (Merrimack Pharma, Bayer and HealthCare Pharma). He is the Head of the IASGO Cancer Research Section since 2013, and the Secretary General of the IASGO since 2015. In 2016, he was appointed as the Director of Translational Research in GI Cancer in the Department of Radiation Oncology at MGH Cancer Center. (See full CV below.)